Browse by category

Magnetic sphincter augmentation feasible, safe and less invasive option vs RYGB for post-sleeve GERD

A systematic review has concluded that magnetic sphincter augmentation may represent a feasible, safe, and less invasive option compared...

BMS may lower risk of pancreatic cancer in people with obesity

Bariatric and metabolic surgery may lower the risk of developing pancreatic cancer in people with obesity especially in those who also...

Costs of obesity management medications exceeds BMS in less than a year

The cost of taking weekly injections of popular obesity management medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that...

LSG with Nissen Fundoplication has higher prevalence of comorbidities and a longer hospital length of stay

Patients who underwent laparoscopic sleeve gastrectomy (LSG) with Nissen Fundoplication (NF) had a higher prevalence of comorbidities and...

EndoZip Endoscopic Suturing System results in an average TBWL of 13.21% at 12 months

The outcomes from a multi-centre study have revealed the effectiveness of the EndoZip system in achieving significant weight loss, with...

Bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

For patients with type 2 diabetes, obesity and chronic kidney disease, bariatric surgery was associated with a significant decrease in...

23 US states more than one in three adults has obesity

The latest CDC population data from 2023 show that in 23 states more than one in three adults (35%) has obesity. Before 2013, no state...

Bariatric surgery may help people with obesity manage hypertension

People living with obesity who underwent bariatric surgery were more likely to control their hypertension over a one-to-five-year...

REBORN study: How to prioritise patients for BMS leading to the appropriate selection

Improvements in the physical component of quality of life (QoL) after metabolic and bariatric surgery (MBS) varies for patients with...

Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investment

Expanding the capacity of bariatric and metabolic surgery (BMS) capacity in England beyond a small proportion of the eligible population...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

3 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

3 days ago

Racial and ethnic groups face barriers to obtaining OMMs

3 days ago

Weekly Digest